LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS

Multiple active component therapeutic formulations are described comprising at least two active agents selected from the group consisting of an isovanillin component, a harmine component, and a curcumin component, stabilized in a self-supporting lipid crystalline formulation for topical application....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PRONIUK, Stefan, LINDAL, Åke Richard, NILSSON, Anette Susanne, ZAID, Gene H, MOORE, Robert Preston, WEST, Cameron E
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PRONIUK, Stefan
LINDAL, Åke Richard
NILSSON, Anette Susanne
ZAID, Gene H
MOORE, Robert Preston
WEST, Cameron E
description Multiple active component therapeutic formulations are described comprising at least two active agents selected from the group consisting of an isovanillin component, a harmine component, and a curcumin component, stabilized in a self-supporting lipid crystalline formulation for topical application. The formulation maintains the active agents in a stable form during storage and will melt at body temperature when applied to the skin, wherein the lipid crystals melt into a liquid crystalline structure thereby releasing the active agents to the applied area of the skin or tissue to render their therapeutic effect. La divulgation concerne de multiples formulations thérapeutiques à composants actifs comprenant au moins deux agents actifs choisis dans le groupe constitué par un composant isovanilline, un composant harmine et un composant curcumine, stabilisés dans une formulation cristalline lipidique autoportante pour application topique. La formulation maintient les agents actifs sous une forme stable pendant le stockage et fond à la température corporelle lorsqu'elle est appliquée sur la peau, les cristaux lipidiques fondant dans une structure cristalline liquide, libérant ainsi les agents actifs vers la zone appliquée de la peau ou du tissu pour qu'ils confèrent leur effet thérapeutique.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022261466A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022261466A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022261466A13</originalsourceid><addsrcrecordid>eNqNjMEKgkAQQL10iOofBjoHuYX3cR1zYNsRHRRPIrHRIUqw_yeLPqDTe4fHW0Y3xyVnYKuuVnSOPYGVcyk1K4uvoWUtgHyB3lIGc5OyY-0glwpUSrboICPHDVUdSA5odXbAE3n9nFL2-D2to8V1uE9h8-Mq2uakttiF8dmHaRwu4RFefStmb4xJ4mOSYHz4r3oDNJU25A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS</title><source>esp@cenet</source><creator>PRONIUK, Stefan ; LINDAL, Åke Richard ; NILSSON, Anette Susanne ; ZAID, Gene H ; MOORE, Robert Preston ; WEST, Cameron E</creator><creatorcontrib>PRONIUK, Stefan ; LINDAL, Åke Richard ; NILSSON, Anette Susanne ; ZAID, Gene H ; MOORE, Robert Preston ; WEST, Cameron E</creatorcontrib><description>Multiple active component therapeutic formulations are described comprising at least two active agents selected from the group consisting of an isovanillin component, a harmine component, and a curcumin component, stabilized in a self-supporting lipid crystalline formulation for topical application. The formulation maintains the active agents in a stable form during storage and will melt at body temperature when applied to the skin, wherein the lipid crystals melt into a liquid crystalline structure thereby releasing the active agents to the applied area of the skin or tissue to render their therapeutic effect. La divulgation concerne de multiples formulations thérapeutiques à composants actifs comprenant au moins deux agents actifs choisis dans le groupe constitué par un composant isovanilline, un composant harmine et un composant curcumine, stabilisés dans une formulation cristalline lipidique autoportante pour application topique. La formulation maintient les agents actifs sous une forme stable pendant le stockage et fond à la température corporelle lorsqu'elle est appliquée sur la peau, les cristaux lipidiques fondant dans une structure cristalline liquide, libérant ainsi les agents actifs vers la zone appliquée de la peau ou du tissu pour qu'ils confèrent leur effet thérapeutique.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221215&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022261466A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221215&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022261466A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PRONIUK, Stefan</creatorcontrib><creatorcontrib>LINDAL, Åke Richard</creatorcontrib><creatorcontrib>NILSSON, Anette Susanne</creatorcontrib><creatorcontrib>ZAID, Gene H</creatorcontrib><creatorcontrib>MOORE, Robert Preston</creatorcontrib><creatorcontrib>WEST, Cameron E</creatorcontrib><title>LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS</title><description>Multiple active component therapeutic formulations are described comprising at least two active agents selected from the group consisting of an isovanillin component, a harmine component, and a curcumin component, stabilized in a self-supporting lipid crystalline formulation for topical application. The formulation maintains the active agents in a stable form during storage and will melt at body temperature when applied to the skin, wherein the lipid crystals melt into a liquid crystalline structure thereby releasing the active agents to the applied area of the skin or tissue to render their therapeutic effect. La divulgation concerne de multiples formulations thérapeutiques à composants actifs comprenant au moins deux agents actifs choisis dans le groupe constitué par un composant isovanilline, un composant harmine et un composant curcumine, stabilisés dans une formulation cristalline lipidique autoportante pour application topique. La formulation maintient les agents actifs sous une forme stable pendant le stockage et fond à la température corporelle lorsqu'elle est appliquée sur la peau, les cristaux lipidiques fondant dans une structure cristalline liquide, libérant ainsi les agents actifs vers la zone appliquée de la peau ou du tissu pour qu'ils confèrent leur effet thérapeutique.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKgkAQQL10iOofBjoHuYX3cR1zYNsRHRRPIrHRIUqw_yeLPqDTe4fHW0Y3xyVnYKuuVnSOPYGVcyk1K4uvoWUtgHyB3lIGc5OyY-0glwpUSrboICPHDVUdSA5odXbAE3n9nFL2-D2to8V1uE9h8-Mq2uakttiF8dmHaRwu4RFefStmb4xJ4mOSYHz4r3oDNJU25A</recordid><startdate>20221215</startdate><enddate>20221215</enddate><creator>PRONIUK, Stefan</creator><creator>LINDAL, Åke Richard</creator><creator>NILSSON, Anette Susanne</creator><creator>ZAID, Gene H</creator><creator>MOORE, Robert Preston</creator><creator>WEST, Cameron E</creator><scope>EVB</scope></search><sort><creationdate>20221215</creationdate><title>LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS</title><author>PRONIUK, Stefan ; LINDAL, Åke Richard ; NILSSON, Anette Susanne ; ZAID, Gene H ; MOORE, Robert Preston ; WEST, Cameron E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022261466A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PRONIUK, Stefan</creatorcontrib><creatorcontrib>LINDAL, Åke Richard</creatorcontrib><creatorcontrib>NILSSON, Anette Susanne</creatorcontrib><creatorcontrib>ZAID, Gene H</creatorcontrib><creatorcontrib>MOORE, Robert Preston</creatorcontrib><creatorcontrib>WEST, Cameron E</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PRONIUK, Stefan</au><au>LINDAL, Åke Richard</au><au>NILSSON, Anette Susanne</au><au>ZAID, Gene H</au><au>MOORE, Robert Preston</au><au>WEST, Cameron E</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS</title><date>2022-12-15</date><risdate>2022</risdate><abstract>Multiple active component therapeutic formulations are described comprising at least two active agents selected from the group consisting of an isovanillin component, a harmine component, and a curcumin component, stabilized in a self-supporting lipid crystalline formulation for topical application. The formulation maintains the active agents in a stable form during storage and will melt at body temperature when applied to the skin, wherein the lipid crystals melt into a liquid crystalline structure thereby releasing the active agents to the applied area of the skin or tissue to render their therapeutic effect. La divulgation concerne de multiples formulations thérapeutiques à composants actifs comprenant au moins deux agents actifs choisis dans le groupe constitué par un composant isovanilline, un composant harmine et un composant curcumine, stabilisés dans une formulation cristalline lipidique autoportante pour application topique. La formulation maintient les agents actifs sous une forme stable pendant le stockage et fond à la température corporelle lorsqu'elle est appliquée sur la peau, les cristaux lipidiques fondant dans une structure cristalline liquide, libérant ainsi les agents actifs vers la zone appliquée de la peau ou du tissu pour qu'ils confèrent leur effet thérapeutique.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022261466A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A36%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PRONIUK,%20Stefan&rft.date=2022-12-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022261466A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true